Neos Therapeutics Announces Pricing of Underwritten Public Offering of $25.0 Million of Common Stock
Feb 03, 2017 13:30 pm UTC| Business
DALLAS/FORT WORTH, Texas, Feb. 03, 2017 -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its...
Amyris Provides Business Update
Feb 03, 2017 13:30 pm UTC| Business
Will Report Record Revenue in Both Collaborations and Product Sales for 2016; Near-Term Debt Maturities Have Been Resolved; Completed Strategic Transition Out of Commodity Products EMERYVILLE, Calif., Feb. 03, 2017 --...
Tuesday Morning Corporation Announces Second Quarter Fiscal 2017 Results
Feb 03, 2017 13:30 pm UTC| Business
DALLAS, Feb. 03, 2017 -- Tuesday Morning Corporation (NASDAQ:TUES), a leading off-price retailer currently with 720 stores across the United States specializing in selling deeply-discounted, upscale decorative home...
Global Food Additives Market will reach USD 41.00 Billion by 2022: Zion Market Research
Feb 03, 2017 13:12 pm UTC| Business
Sarasota, FL, Feb. 03, 2017 -- Zion Market Research has published a new report titled “Food Additives Market by Type (Flavors, Hydrocolloids, Acidulants, Colors, Emulsifiers, Preservatives and Sweeteners), by Source...
Feb 03, 2017 13:01 pm UTC| Business
PARIS, Feb. 03, 2017 -- Neovacs (Alternext Paris:ALNEV), a leader in active immunotherapy for the treatment of autoimmune diseases, today announced that it received a positive data review from the Independent Data and...
Feb 03, 2017 13:01 pm UTC| Business
PARIS, Feb. 03, 2017 -- Neovacs (Alternext Paris:ALNEV), a leader in active immunotherapy for the treatment of autoimmune diseases, today announced that it received a positive data review from the Independent Data and...
Pernix Therapeutics Provides Update on Arbitration
Feb 03, 2017 13:01 pm UTC| Business
MORRISTOWN, N.J., Feb. 03, 2017 -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company with a focus on Pain and CNS conditions, today provided an update on the Company’s arbitration with...